DRUMMOND, MICHAEL
 Distribuzione geografica
Continente #
NA - Nord America 1.121
EU - Europa 977
AS - Asia 348
SA - Sud America 8
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 2.460
Nazione #
US - Stati Uniti d'America 1.065
IT - Italia 277
IE - Irlanda 254
CN - Cina 139
GB - Regno Unito 112
UA - Ucraina 87
SE - Svezia 62
SG - Singapore 58
CA - Canada 54
DE - Germania 53
TR - Turchia 44
FI - Finlandia 38
VN - Vietnam 30
FR - Francia 22
KR - Corea 21
HK - Hong Kong 20
IN - India 15
BG - Bulgaria 12
ID - Indonesia 12
DK - Danimarca 10
NL - Olanda 10
CZ - Repubblica Ceca 9
BE - Belgio 6
ES - Italia 5
AT - Austria 4
BR - Brasile 4
JP - Giappone 3
LV - Lettonia 3
CH - Svizzera 2
EC - Ecuador 2
EU - Europa 2
GR - Grecia 2
IR - Iran 2
PT - Portogallo 2
RO - Romania 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
CO - Colombia 1
EE - Estonia 1
HR - Croazia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 2.460
Città #
Dublin 254
Chandler 182
Milan 114
Ashburn 100
Houston 86
Jacksonville 72
New York 58
Ann Arbor 57
Southend 51
Singapore 47
Toronto 44
Dearborn 36
Wilmington 30
Helsinki 28
Dong Ket 26
Beijing 24
Lawrence 24
Seoul 21
Boston 20
Hong Kong 20
Modena 20
Mountain View 19
Izmir 18
Washington 18
Redmond 17
Boardman 15
Redwood City 14
Palombara Sabina 13
Jakarta 12
Dallas 9
Los Angeles 9
Seattle 9
Munich 8
Rome 8
Hefei 7
Riposto 7
Pozzuolo Martesana 5
Woodbridge 5
Amsterdam 4
Las Vegas 4
Manchester 4
Nanjing 4
Shanghai 4
Vancouver 4
Atlanta 3
Barcelona 3
Duncan 3
Egg Harbor Township 3
Espoo 3
Fairfield 3
Grez-Doiceau 3
London 3
Nardò 3
Pune 3
Riga 3
Robbiate 3
Uxbridge 3
Vienna 3
York 3
Brno 2
Brussels 2
Burke 2
Cambridge 2
Forlì 2
Frankfurt am Main 2
Guangzhou 2
Jinan 2
Ladispoli 2
Nanchang 2
Nice 2
Ottawa 2
Para 2
Paris 2
San Francisco 2
Tappahannock 2
Tokyo 2
Yellowknife 2
Aarhus 1
Andover 1
Angera 1
Ankara 1
Athens 1
Auburn Hills 1
Belgrade 1
Bergamo 1
Berlin 1
Bishkek 1
Bologna 1
Bonndorf 1
Bucharest 1
Buffalo 1
Centro 1
Cesa 1
Changchun 1
Chennai 1
Chongqing 1
Clifton 1
Copenhagen 1
Cormeilles-en-Parisis 1
Council Bluffs 1
Totale 1.635
Nome #
Economic evaluation of medical devices 175
Public Versus Private Financing 160
The role of hospital payments in the adoption of new medical technologies: an international survey of current practice 150
Myth #5: health care is rightly left to the private sector, for the sake of efficiency 148
Diffusion without evidence: a study on high-risk medical devices 140
Do social values and institutional context shape the use of economic evaluation in reimbursement decisions? An empirical analysis 134
Challenges in the assessment of medical devices: the MedtecHTA Project 132
Key reccomendations from the MedtecHTA project 128
Does the approach to economic evaluation in health care depend on culture, values, and institutional context? 124
Should health technology assessment be more patient centric? If so, how? 108
Time to review the role of surrogate end points in health policy: state of the art and the way forward 101
Generating appropriate clinical data for value assessment of medical devices: what role does regulation play? 94
Incentivizing research into the effectiveness of medical devices 92
Coverage with evidence development for medical devices in Europe: can practice meet theory? 88
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal 84
Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges 74
European Union regulation of health technology assessment: what is required for it to succeed? 71
Challenges with coverage with evidence development schemes for medical devices: a systematic review 70
Economic evaluation of nutrition interventions: does one size fit all? 66
Consideration of quality of life in the health technology assessments of rare disease treatments 64
The estimation of health state utility values in rare diseases: overview of existing techniques 62
‘Mapping’ health state utility values from non-preference-based measures: a systematic literature review in rare diseases 59
Performance-based risk-sharing agreements in renal care: current experience and future prospects 55
The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review 54
Quo vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges 48
Mapping payment and pricing schemes for health innovation: protocol of a scoping literature review 36
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy? 30
Design and features of pricing and payment schemes for health technologies: a scoping review and a proposal for a flexible need-driven classification 9
Totale 2.556
Categoria #
all - tutte 13.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.618


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020214 0 0 0 0 0 0 66 43 30 32 23 20
2020/2021282 19 24 7 27 35 18 25 9 29 11 19 59
2021/2022298 10 41 4 6 24 4 13 50 18 39 45 44
2022/2023653 41 49 11 54 55 48 1 35 309 13 22 15
2023/2024490 16 22 46 8 46 118 28 62 7 13 70 54
2024/2025168 12 21 39 20 48 28 0 0 0 0 0 0
Totale 2.556